Targeting Notch-1 positive acute leukemia cells by novel fucose-bound liposomes carrying daunorubicin

Complete remission by induction therapy in acute myelogenous leukemia (AML) can be achieved due to improvements in supportive and optimized therapy. However, more than 20% of patients will still need to undergo salvage therapy, and most will have a poor prognosis. Determining the specificity of drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Ono, Michihiro, Takimoto, Rishu, Osuga, Takahiro, Okagawa, Yutaka, Hirakawa, Masahiro, Yoshida, Makoto, Arihara, Yohei, Uemura, Naoki, Hayasaka, Naoki, Miura, Shogo, Matsuno, Teppei, Tamura, Fumito, Sato, Yasushi, Sato, Tsutomu, Iyama, Satoshi, Miyanishi, Koji, Takada, Kohichi, Kobune, Masayoshi, Kato, Junji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122413/
https://www.ncbi.nlm.nih.gov/pubmed/27233074
http://dx.doi.org/10.18632/oncotarget.9558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122413/
https://www.ncbi.nlm.nih.gov/pubmed/27233074
http://dx.doi.org/10.18632/oncotarget.9558

Ejemplares similares